Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Botnar Research Centre, Old Road, Headington, Oxford, OX3 7LD

Hannah Rome-Hall


MelMarT-II Trial Manager

On maternity leave

I was appointed as the MelMarT-II Trial Manager at the end of November 2021 and have previously worked as a Clinical Trials Assistant, Research Coordinator and Clinical Project Manager in various clinical settings, including CRO, a pharmaceutical company and at a clinical trial site. I have a degree in biochemistry, which I obtained from the University of Bath and completed a placement year with GlaxoSmithKline.

My research is on whether there is a difference in disease free survival for patients treated with either a 1cm excision margin or 2cm margin for clinical stage II (pT2b-pT4b) primary cutaneous melanoma. This research is important because it is designed to show that the risk of long-term pain associated with surgery can be reduced with a smaller margin. 

It is expected that successful completion of this study will define the appropriate management of Stage II primary cutaneous melanoma (pT2b-pT4b) for Australia and the international melanoma community.

When not working I enjoy playing netball and I help to run the netball club in Wallingford. I also swim and completed my first half marathon in September 2021. I plan to run another half marathon this year.